Currently active FOAs for neuroscience research include the following Requests for Applications (RFAs), Program Announcements (PAs), and PAs with special reviews (PARs), as well as Notices (NOTs).
FOAs on which the NICHD is the primary sponsor
- RFA-HD-22-020 Human Milk as a Biological System (R01 Clinical Trial Optional)
- RFA-HD-22-009 Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional)
- RFA-HD-22-008 Autism Centers of Excellence: Networks (P50 Clinical Trial Optional)
- RFA-HD-22-007 Autism Centers of Excellence: Networks (R01 Clinical Trial Optional)
- RFA-HD-22-005 Learning Disabilities Innovation Hubs (P20 Clinical Trial Optional)
- PAR-HD-21-229 Screening and Functional Validation of Human Birth Defects Genomic Variants (R01 Clinical Trial Not Allowed)
- PAR-21-115 Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
- NOT-HD-21-039 Notice of Intent to Publish a Funding Opportunity Announcement for Innovative Therapies and Tools for Screenable Disorders in Newborns
- NOT-HD-21-037 Notice of Special Interest (NOSI): Competitive Revision and Administrative Supplements to Existing NICHD HIV Grants and Cooperative Agreements to Understand HIV Health Impacts of COVID-19
- NOT-HD-21-032 NOSI: Reduction of Sudden Unexpected Infant Death and Sudden Infant Death Syndrome
- NOT-HD-21-026 NOSI: Research on the Impact of the Covid 19 Pandemic and Risks for Abuse and Injury Among Vulnerable Children and Youth
- NOT-HD-21-025 NOSI: Reproductive Health, Pregnancy, and Parenting Among Women with Disabilities
- PAR-20-298 Development of the Fetal Immune System (R01 Clinical Trial Not Allowed)
- PAR-20-282 Fertility Status as a Marker for Overall Health (R21 Clinical Trial Not Allowed)
- PAR-20-281 Fertility Status as a Marker for Overall Health (R01 Clinical Trial Optional)
- PAR-20-137 In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
- PAR-20-101 Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)
- PAR-20-064 Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
- PAR-20-033 Human-Animal Interaction (HAI) Research (R21 Clinical Trial Optional)
- PAR-20-032 Human-Animal Interaction (HAI) Research (R03 Clinical Trial Optional)
- PAR-20-031 Human-Animal Interaction (HAI) Research (R01 Clinical Trial Optional)
- NOT-HD-20-032 NOSI: Using Systems Science Methodologies to Protect and Improve Child and Reproductive Population Health
- NOT-HD-20-031 NOSI: Research on Rehabilitation Needs Associated with the COVID-19 Pandemic
- NOT-HD-20-026 NOSI: Optimizing Precision Treatment of Gynecologic, Reproductive and Obstetrical Outcomes in Adolescents and Adults with PCOS and Associated Comorbid Conditions (Clinical Trial Optional)
- NOT-HD-20-025 NOSI: Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44)
- NOT-HD-20-022 Small Grants for Secondary Analyses of Existing Data Sets and Stored Biospecimens
- NOT-HD-20-021 NOSI: Emerging Viral Infections and their Impact on the Male and Female Reproductive Tract
- NOT-HD-20-009 Notice of Interest in Advancing Research on FMR1-Associated Conditions
- NOT-HD-20-004 NOSI: Biophysical and Biomechanical Aspects of Embryonic Development (R21)
- NOT-HD-19-038 NOSI: Biophysical and Biomechanical Aspects of Embryonic Development (R21)
- NOT-HD-19-037 NOSI: Biophysical and Biomechanical Aspects of Embryonic Development (R01)
- NOT-HD-19-022 NOSI: Research on Emergency Medical Services for Children (EMSC)
- NOT-HD-19-020 NOSI: Mechanisms Underlying the Contribution of Sleep Disturbances to Pain
FOAs on which the NICHD is a partner
- NOT-NS-22-003 NOSI: Advancing Research in Gastrointestinal Dysfunction in People with Neurodevelopmental Disorders
- RFA-NS-21-026 BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
- RFA-NS-21-027 BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
- NOT-OD-21-087 NOSI: Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being
- NOT-EB-21-008 Notice of NIH Participation in the National Robotics Initiative
- NOT-EB-21-001 NOSI: Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health
- PAR-21-319 Global Brain and Nervous System Disorders Research Across the Lifespan (R21 Clinical Trial Optional)
- PAR-21-311 Global Brain and Nervous System Disorders Research Across the Lifespan (R01 Clinical Trial Optional)
- PAR-21-281 Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 Clinical Trial Not Allowed)
- PAR-21-280 Dyadic Interpersonal Processes and Biopsychosocial Outcomes (R01 - Basic Experimental Studies with Humans)
- PA-21-201 Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)
- PA-21-200 Research on Autism Spectrum Disorders (R21 Clinical Trial Optional)
- PA-21-199 Research on Autism Spectrum Disorders (R03 Clinical Trial Optional)
- PAR-21-100 Music & Health: Understanding and Developing Music Medicine (R01 Clinical Trial Optional)
- PAR-21-099 Music & Health: Understanding and Developing Music Medicine (R21 Clinical Trial Optional)
- RFA-HG-21-037 Limited Competition: Knockout Mouse Phenotyping Project Data Coordination Center and Database (UM1 Clinical Trial Not Allowed)
- RFA-HG-21-036 Limited Competition: Knockout Mouse Production and Phenotyping Project (UM1 Clinical Trial Not Allowed)
- PA-20-227 Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed)
- PAR-20-180 Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)
- PAR-20-179 Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)
- PAR-20-169 National Centers for Biomedical Engineering and Bioimaging (NCBIB) (P41 Clinical Trials Optional)
- NOT-TR-20-006 NOSI: Availability of Administrative Supplements for the Rare Disease Clinical Research Network (RDCRN)
- NOT-NS-20-005 NOSI: Research in the Emergency Setting
- PAR-19-292 Mechanistic Studies of Gene-Environment Interplay in Dental, Oral, Craniofacial, and Other Diseases and Conditions (R01 Clinical Trial Not Allowed)
- PAR-19-276 Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)
- PAR-19-274 Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)
- PAR-19-163 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)
- PAR-19-158 Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
- NOT-MD-19-001 NOSI: Research on the Health of Sexual and Gender Minority (SGM) Populations
- PAR-18-953 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
- PAR-18-952 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
- PAR-18-939 Research on Chronic Overlapping Pain Conditions (R21 Clinical Trial Not Allowed)
- PAR-18-937 Research on Chronic Overlapping Pain Conditions (R01 Clinical Trial Optional)
In addition, neuroscience researchers may also be interested in funding opportunities for the following trans-NIH initiatives in which NICHD participates:
- Active FOAs related to the NIH Blueprint for Neuroscience Research
- Funding information for the NIH BRAIN Initiative
- Funding information for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
- Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM Funding
- Funding related to NIH’s Strategic Response to COVID-19
BACK TO TOP